2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Breast Neoplasms
6
Triple Negative Breast Neoplasms
3
Recurrence
3
Prostatic Neoplasms
3
Urinary Bladder Neoplasms
2
Neoplasms
2
Neoplasm Metastasis
2
Carcinoma, Non-Small-Cell Lung
2
Turcot syndrome
1
Thyroid Neoplasms
1
Tertiary Lymphoid Structures
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Non-Muscle Invasive Bladder Neoplasms
1
Multiple Myeloma
1
Mucopolysaccharidosis I
1
Mesothelioma, Malignant
1
Lymphoma, T-Cell, Peripheral
1
Liposarcoma
1
Inhibition of Autophagy Synergizes Anti-tumor Effect
1
Immunoblastic Lymphadenopathy
1
Hodgkin Disease
1
Genetic Diseases, Inborn
1
Gastrointestinal Neoplasms
1
Gastro-enteropancreatic neuroendocrine tumor
1
Interventions
Melphalan
3
Blood Specimen Collection
3
Magnetic Resonance Spectroscopy
2
thymoglobulin
1
sargramostim
1
romidepsin
1
montanide ISA 51
1
keyhole-limpet hemocyanin
1
ixazomib
1
detox adjuvant
1
Waiting Lists
1
Ursodeoxycholic Acid
1
Transplantation
1
Thalidomide
1
Tablets
1
Surveys and Questionnaires
1
Streptozocin
1
Specimen Handling
1
Restraint, Physical
1
Radiosurgery
1
Radiation
1
Mercaptopurine
1
Leucovorin
1
Ketoconazole
1
Interleukin-2
1
Fulvestrant
1
Floxuridine
1
FANG vaccine
1
Docetaxel
1
Diagnostic Tests, Routine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Genetic Diseases, Inborn
×
Clinical Trials, Phase II as Topic
×
Clear all
NCT03683277
2025-02-19
IFM2014-01
Intergroupe Francophone du Myelome
Phase 2
Terminated
26 enrolled